(
)
B. Bildstein et al.rJournal of Organometallic Chemistry 552 1998 45–61
59
1
w
Ž
Ž
.
Data for trans-bis 1-ferrocenylmethyl-3-methyl-be-
1-ferrocenylmethyl-3-methyl-benzimidazole . H NMR
x
Ž .
.
Ž
.
Ž
.
nzimidazoline-2-ylidene -diiodopalladium II 10: yellow
crystals, m.p. not observed up to 3308C. Anal. Found:
DMF-d7 : d 4.25 6H, s, CH3 , 4.29 10H, s, Cpunsubst ,
4.33–4.80 8H, m, Cpsubst , 5.89 4H, s, CH2 , 7.51–8.0
8H, m, benzimidazole . C NMR DMF-d7 : d 30.04
CH3 ; 47.37, 48.03 CH2 ; 69.06, 69.43, 69.63, 70.42,
70.83 Cpsubst and Cpunsubst ; 112.62, 113.09, 113.44,
113.83, 114.11, 114.33, 125.41, 125.85, 127.28, 142.94
Ž
.
Ž
.
13
Ž
Ž
.
Ž
.
C, 44.67; H, 3.59. C38 H36 Fe2 I2 N4 Pd. Calcd.: C, 44.72;
H, 3.56%. IR KBr : cm
1460m, 1443s, 1404m, 1391s, 1177w, 1107m, 1043m,
y1
Ž
.
.
Ž
.
3081w, 2929w, 1479s,
Ž
.
Ž
.
1024s, 1001s, 818s, 802s, 750s, 501s, 482s. MS FAB :
q
Ž
.
Ž
. Ž
.
Ž
.
mrz % 1020 100
M . Due to insufficient solubility
benzimidazole .
w
andror decomposition in solution no NMR data could
Data for bis 1-ferrocenylmethyl-3-methyl-benzimi-
X
x
Ž .
be obtained.
dazoline-2-ylidene diiodo-mm -diiodo-dimercury II 13:
yellow crystals, m.p. 2008C, dec. Anal. Found: C, 29.02;
H, 2.35. C38 H36 Fe2yH1g2 I4 N4. Calcd.: C, 29.09; H,
w
Ž
.
Data for bis 1,3-di ferrocenylmethyl benzimidazo-
line-2-ylidene -diiodopalladium II 11: yellow crystals,
m.p. not observed up to 3308C. Anal. Found: C, 50.10;
H, 3.80. C58 H52 Fe4 I2 N4 Pd. Calcd.: C, 50.16; H, 3.77%.
IR KBr : cm 3093w, 2925w, 1616m, 1514w, 1478s,
1443m, 1410s, 1393s, 1366m, 1339m, 1171w, 1150s,
x
Ž .
Ž
.
2.31%. IR KBr : cm
3075w, 2944w, 1481s, 1456s,
1410s, 1395s, 1346m, 1335s, 1261m, 1103m, 1016m,
816m, 798s, 789m, 766w, 754s, 737s, 499s, 482m.
y1
Ž
.
q
q
Ž
.
Ž
.
Ž . Ž
.
Ž
. Ž
MS ESI : mrz % 1446 4 M qH , 988 100 M –
1
q
Ž
.
.
Ž
. Ž
.
Ž
1041m, 1024m, 1001m, 820s, 742s, 499s. MS FAB :
HgI2 , 658 20 M –HgI4–FcCH2 . H NMR DMF-
mrz % 1388 30
M
, 1189 10 M –FcCH2 . 1H
q
q
Ž
.
Ž
. Ž
.
Ž
. Ž
.
Ž
.
Ž
.
d7 : d 3.49 6H, s, CH3 ; 5.71, 5.75, 5.81, 5.87, 5.95
22H, m, Cpunsubst, Cpsubst, CH2 ; 7.54–8.07 8H, m,
benzimidazole . C NMR DMF-d7 due to decompo-
sition during accumulation of the FID only a few of the
expected signals were observed : d 69.25, 69.58, 69.67,
70.67, 70.81 Cpsubst and Cpunsubst ; 113.62, 125.76
benzimidazole . X-ray structure Tables 1 and 7; Fig.
6 : single crystals were obtained from a saturated DMF
Ž
.
Ž
.
Ž
NMR CDCl3 : d 4.16, 4.21, 4.31, 4.73, 4.76 16H,
each signal: m, CH2 , 4.26 20H, s, Cpunsubst , 5.92 s,
4H, CH2 , 5.98 s, 4H, CH2 , 6.98–7.45 m, 8H,
benzimidazole . C NMR CDCl3 : d 45.7, 49.6, 50.8
13
.
Ž
.
Ž
.
Ž
. Ž
.
Ž
.
Ž
13
.
Ž
.
.
Ž
.
Ž
Ž
.
.
CH2 ; 68.3, 68.4, 69.0, 69.2, 70.7, 70.8 Cpsubst and
.
Ž Ž .
.
Ž
Ž
Cpunsubst ; 80.9, 82.3 C 1 of Cpsubst ; 110.5, 111.2,
111.8, 121.7, 122.2, 122.3, 123.2, 124.1, 134.6, 134.7,
.
Ž
.
Ž
.
144.2 benzimidazole ; 179.4 carbene-C . X-ray struc-
ture of trans–anti isomer Tables 1 and 6; Fig. 5 :
single crystals were obtained from dichloromethane.
solution at y258C.
Ž
.
w
Data for bis 1-ferrocenylmethyl-3-methyl-imidazo-
line-2-ylidene mercury II diiodide 12b: yellow crystals,
m.p. 2008C, dec. Anal. Found: C, 35.47; H, 3.21.
C30 H32 Fe2 HgI2 N4. Calcd.: C, 35.51; H, 3.18%.
IR KBr : cm 3143w, 3093m, 1634m, 1564m, 1464s,
1439m, 1412s, 1215s, 1105s, 1040m, 1026m, 1001s,
x
Ž .
( )
4.10. Mercury II complexes 12a,b, 13, 14a,b, 15
y1
Ž
Ž
.
Mixtures of azolium halogenides 2a,b, 3a,b, 5 XsI
.
or Br were refluxed for 40 min in THF with 0.5 mole
Ž .
Ž
.
Ž
.
Ž
.
equivalents of mercury II acetate: 0.2 g 0.4 mmol
818s, 754s, 733s, 505s, 484s. MS ESI : mrz %
1
q
Ž
.
Ž
.
Ž
Ž
. Ž
.
Ž
Ž
.
2a-iodider70 mg 0.2 mmol Hg OAc ; 212 mg 0.5
889 100 M q1H–I . H NMR DMF-d7 : d 3.45
.
Ž
.
2 Ž
.
Ž
.
Ž
.
Ž
Ž
mmol 2b-iodider83 mg 0.25 mmol Hg OAc ; 0.2 g
6H, s, CH3 , 4.04 2H, m, Cpsubst , 4.12 2H, m,
2
Ž
Ž
.
Ž
.
Ž
.
.
.
.
0.3 mmol 3a-iodider50 mg 0.15 mmol Hg OAc ;
Cpsubst , 4.27 10H, s, Cpunsubst , 4.49 2H, m, Cpsubst ,
4.60 2H, m, Cpsubst ; 5.60, 5.79 4H, s, CH2 ; 7.61,
7.72, 7.74, 7.85 4H, imidazole . C NMR DMF-d7 :
d 43.81 CH3 ; 55.31, 55.99 CH2 ; 74.50, 74.72, 75.27
2
Ž
.
.
Ž
.
Ž
.
228 mg 0.4 mmol 3b-iodider60 mg 0.19 mmol
13
Ž
.
Ž
.
Ž
Ž
.
Ž
.
Hg OAc ; 92 mg 0.14 mmol 5-bromider24 mg 0.07
.
2 Ž
.
Ž
.
Ž
.
mmol Hg OAc ; respectively. During this reflux pe-
2
Ž
Ž
.
riod a color change yellow-brown-tan took place. For
work-up THF was removed on a rotary evaporator, the
residues were washed with three portions of ether, and
the crude products were dissolved in dichloromethane
and crystallized by addition of a small layer of hexane,
Cpsubst and Cpunsubst ; 127.59, 128.61, 130.06, 130.50
.
imidazole .
w
Ž
.
Data for bis 1,3-di ferrocenylmethyl benzimidazo-
line-2-ylidene mercury II diiodide 14a: yellow crystals,
m.p. 1808C, dec. Anal. Found: C, 46.95; H, 3.50.
C58 H52 Fe4 HgI2 N4. Calcd.: C, 46.98; H, 3.53%.
IR KBr : cm 3094w, 2938w, 1634m, 1559s, 1476w,
1447s, 1412s, 1395w, 1319w, 1105s, 1041m, 1028m,
x
Ž .
Ž
.
Ž
resulting in: 90 mg 0.08 mmol, 37% 12a; 60 mg 0.04
y1
.
Ž
.
Ž
.
mmol, 20.7% 13; 133 mg 0.13 mmol, 56.6% 12b; 50
Ž
.
Ž
.
mg 0.03 mmol, 21.6% 14a; 72 mg 0.05 mmol, 27%
Ž
.
Ž
.
14b; 55 mg 0.04 mmol, 49% 15; respectively.
1013w, 1001s, 820s, 794s, 756m, 501s, 482s. MS ESI :
q
q
w
Ž
.
.
Ž
. Ž
.
Ž
. Ž
.
Data for bis 1-ferrocenylmethyl-3-methyl-benzimi-
mrz % 1356 15 M –I , 1287 53 M –FcCH2 ,
1
x
Ž .
Ž
Ž
.
Ž
.
dazoline-2-ylidene mercury II diiodide 12a: yellow
crystals, m.p. 2008C, dec. Anal. Found: C, 40.88; H,
3.28. C38 H36yF1e2 HgI2 N4. Calcd.: C, 40.94; H, 3.25%.
515 100 . H NMR DMF-d7 : d 4.16 4H, m, Cpsubst ,
Ž
.
Ž
.
Ž
4.23 4H, m, Cpsubst , 4.31 20H, s, Cpunsubst , 4.72 4H,
m, Cpsubst , 4.76 4H, m, Cpsubst , 5.84 8H, s, CH2 ,
7.53–8.27 8H, m, benzimidazole . C NMR DMF-
d7 : d 48.49 CH2 ; 69.36, 69.66, 70.69, 82.56 Cpsubst
.
Ž
.
Ž
.
13
Ž
.
Ž
.
Ž
Ž
IR KBr : cm 3077w, 1568w, 1481m, 1458s, 1408m,
1393m, 1377w, 1337w, 1105m, 1041w, 1016m, 1001m,
.
Ž
.
.
Ž
.
Ž
.
.
Ž
820s, 798s, 787s, 748s, 501s, 482s. MS ESI : mrz %
and Cpunsubst ; 113.9, 114.38, 125.88, 126.37 be-
q
q
Ž
. Ž
.
Ž
. Ž
.
Ž
.
987 75 M –I , 659 30 M –2I–FcCH2 , 331 100
nzimidazole .